Magee-Womens Hospital, UPMC Cancer Pavilion

Pittsburgh, Pennsylvania 15232-1309

0 studies enrolling now · 1 studies all time

What they study most

Inflammatory Breast Cancer Stage IV, Triple Negative Breast Cancer

Studies at this site

• Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC — Stopped early